The 93rd CMEF is set to open in Shanghai, as the world's largest medical device industry exhibition spotlights AI, robotics, and international cooperation

TiumBio to Present Phase 2a Interim Data Highlighting Differentiated Clinical Profile for Tosposertib(TU2218) plus Pembrolizumab in First-Line R/M HNSCC at ASCO 2026

United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026

HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited

Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm

Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

BIELAT SANTORE & COMPANY SELLS SOUTH JERSEY SPORTS BAR & RESTAURANT

New First-in-Class Therapy for Chronic Graft-Versus-Host Disease Approved in Australia[1]

Everads Announces Publication of First-in-Human Clinical Data for Its Suprachoroidal Injector in Ophthalmology Science and Three Presentations at ARVO 2026

Spinogenix to Present Preclinical Results at ARVO 2026 Demonstrating Neuroprotective Effects of Tazbentetol in Glaucoma and Diabetic Retinopathy Models

VARON Celebrates 5 Years Supporting Easier Breathing for Customers Worldwide

Data at Heart Rhythm 2026 highlight key Boston Scientific therapies

Innovation in health begins by creating the right conditions

Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026

In HelloNation, Pediatric Care Expert Phillip Walker Explains the Importance of a Child's Well Visit and How Families Can Prepare

Why Does PureHealth Research Formulate Its Stress Management Supplements with Ashwagandha and Magnesium?

TEAMSTERS AT UNIVERSITY OF CHICAGO MEDICAL CENTER TO HOLD TWO-DAY PRACTICE PICKET

Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)

PureHealth Research GLP-1 Supplements Blend African Mango and Green Coffee Extract for Daily Satiety Support

USHG CEO Chip Wade named 2026 Gold Plate winner

AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026

NPHI and C-TAC Launch Work on a Federal Community-Based Model to Expand Earlier, In-Home Support for Patients Nationwide

PureHealth Research Liver Support Collection Addresses Growing Demand for Natural Hepatic Wellness

NIRSense Supports the US Army in the Indo-Pacific with Tissue Oxygenation Assessment for Battlefield Casualty Care at Balikatan-26

PureHealth Research Announces Berberine-Infused Natural GLP-1 Supplements to Support the Body's Native Metabolic Function

ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D

Lumenis Aesthetics Showcases New Clinical Data Across Skin and Hair Loss Indications at 45th Annual American Society for Laser Medicine and Surgery Conference